Capital Investment Services of America Inc. Boosts Holdings in Danaher Corporation $DHR

Capital Investment Services of America Inc. increased its position in shares of Danaher Corporation (NYSE:DHR) by 0.9% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 134,533 shares of the conglomerate’s stock after purchasing an additional 1,242 shares during the period. Danaher makes up 2.4% of Capital Investment Services of America Inc.’s portfolio, making the stock its 18th largest holding. Capital Investment Services of America Inc.’s holdings in Danaher were worth $26,576,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of DHR. GAMMA Investing LLC lifted its stake in Danaher by 22.2% in the first quarter. GAMMA Investing LLC now owns 9,126 shares of the conglomerate’s stock worth $1,871,000 after acquiring an additional 1,660 shares during the period. Pacific Capital Partners Ltd bought a new stake in shares of Danaher in the 1st quarter valued at about $7,175,000. Oppenheimer & Co. Inc. raised its holdings in shares of Danaher by 9.2% in the 1st quarter. Oppenheimer & Co. Inc. now owns 25,096 shares of the conglomerate’s stock valued at $5,145,000 after purchasing an additional 2,122 shares in the last quarter. Valmark Advisers Inc. lifted its position in shares of Danaher by 3.4% in the 1st quarter. Valmark Advisers Inc. now owns 2,365 shares of the conglomerate’s stock worth $485,000 after purchasing an additional 78 shares during the period. Finally, GHP Investment Advisors Inc. boosted its stake in shares of Danaher by 396.0% during the first quarter. GHP Investment Advisors Inc. now owns 124 shares of the conglomerate’s stock valued at $25,000 after purchasing an additional 99 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Stock Performance

Shares of DHR stock opened at $218.06 on Thursday. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $260.88. The business has a fifty day moving average of $202.24 and a 200 day moving average of $197.73. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. The firm has a market capitalization of $156.14 billion, a price-to-earnings ratio of 44.96, a price-to-earnings-growth ratio of 3.20 and a beta of 0.77.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, beating the consensus estimate of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.93%. The business had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same period in the previous year, the business posted $1.71 EPS. The business’s quarterly revenue was up 4.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, research analysts expect that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is presently 27.23%.

Wall Street Analyst Weigh In

Several brokerages have issued reports on DHR. Bank of America dropped their target price on Danaher from $230.00 to $220.00 and set a “buy” rating on the stock in a research report on Monday, September 22nd. Guggenheim reiterated a “buy” rating and issued a $250.00 target price on shares of Danaher in a research note on Wednesday, July 23rd. Scotiabank raised shares of Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price target for the company in a research report on Friday, July 11th. Royal Bank Of Canada set a $241.00 price objective on shares of Danaher in a research report on Tuesday, September 2nd. Finally, Wells Fargo & Company increased their target price on shares of Danaher from $205.00 to $230.00 and gave the company an “equal weight” rating in a research report on Wednesday. Seventeen equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $243.39.

Insider Activity at Danaher

In other news, Director Teri List sold 2,778 shares of the company’s stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the transaction, the director directly owned 20,751 shares of the company’s stock, valued at $4,379,706.06. This represents a 11.81% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. 11.10% of the stock is owned by company insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.